Axis Wealth Partners LLC trimmed its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 27.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 13,555 shares of the industrial products company’s stock after selling 5,151 shares during the quarter. Axis Wealth Partners LLC’s holdings in Xylem were worth $1,620,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. TSP Capital Management Group LLC grew its stake in shares of Xylem by 0.5% during the first quarter. TSP Capital Management Group LLC now owns 88,014 shares of the industrial products company’s stock valued at $10,518,000 after purchasing an additional 404 shares during the last quarter. IFM Investors Pty Ltd lifted its holdings in Xylem by 0.9% during the 1st quarter. IFM Investors Pty Ltd now owns 50,671 shares of the industrial products company’s stock worth $6,055,000 after buying an additional 459 shares in the last quarter. XXEC Inc. lifted its holdings in Xylem by 477.9% during the 1st quarter. XXEC Inc. now owns 171,211 shares of the industrial products company’s stock worth $20,460,000 after buying an additional 141,586 shares in the last quarter. MQS Management LLC boosted its position in Xylem by 5.1% in the 1st quarter. MQS Management LLC now owns 2,627 shares of the industrial products company’s stock valued at $314,000 after buying an additional 128 shares during the last quarter. Finally, Pathway Financial Advisers LLC boosted its position in Xylem by 16.1% in the 1st quarter. Pathway Financial Advisers LLC now owns 13,782 shares of the industrial products company’s stock valued at $1,647,000 after buying an additional 1,909 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Up 0.8%
NYSE:XYL opened at $118.22 on Friday. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $28.10 billion, a P/E ratio of 29.41, a P/E/G ratio of 1.67 and a beta of 1.03. The stock’s fifty day simple moving average is $112.72 and its 200-day simple moving average is $124.71.
Xylem Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. Xylem’s dividend payout ratio is 42.79%.
Insider Transactions at Xylem
In other news, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Citigroup dropped their target price on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. CLSA upgraded Xylem to a “hold” rating in a report on Thursday, June 25th. Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Finally, Stifel Nicolaus cut their target price on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $153.54.
Get Our Latest Research Report on XYL
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
